TGF-βRII, BAX, IGFIIR, caspase-5, hMSH3 and hMSH6 alterations are not associated with microsatellite instability or p53 mutations in invasive urothelial carcinoma of the urinary bladder

Pathology

Volumn 39, Issue 4, 2007, Pages 425-432

  Saetta, Angelica A ^a,b   Korkolopoulou, Penelope ^a   Karlou, Maria ^a   Levidou, Georgia ^a   Goudopoulou, Athina ^a   Thymara, Irene ^a   Stamatelli, Angeliki ^a   Tzivras, Michalis ^a   Michalopoulos, Nikolaos V ^a   Thomas Tsagli, Euphemia ^a   Patsouris, Efstratios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

BAX; hMSH3; hMSH6; IGFIIR; MSI; TGF RII; Urothelial carcinoma

Indexed keywords

CASPASE 5; PROTEIN BAX; PROTEIN MSH3; PROTEIN MSH6; PROTEIN P53; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; CASP5 PROTEIN, HUMAN; CASPASE; DNA; DNA BINDING PROTEIN; G T MISMATCH BINDING PROTEIN; G-T MISMATCH-BINDING PROTEIN; MSH3 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MOLECULAR BIOLOGY; MULTIVARIATE ANALYSIS; SURVIVAL; UNIVARIATE ANALYSIS; BLADDER TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; CASPASES; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM INVASIVENESS; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, IGF TYPE 2; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 34547702353     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020701444457     Document Type: Article

References (39)

1. Zlotta AR, Schulman CC. Biological response modifiers for the treatment of superficial bladder tumors. Eur Urol 2000; (Suppl 3): 10-5.
2. Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1998; 268: 1336-38.
3. Bonnal C, Ravery V, Toublanc M, et al. Absence of microsatellite instability in transitional cell carcinoma of the bladder. Urology 2000; 55: 287-91.
4. Malkhosyan S, Rambino N, Yamamoto H, et al. Frameshift mutator mutations. Nature 1996; 382: 499-500.
5. Yamamoto H, Sawai H, Perucho M. Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype pathway. Cancer Res 1997; 57: 4420-26.
6. Perucho M. Microsatellite instability: the mutator that mutates the other mutator. Nat Med 1996; 2: 630-1.
7. Yamamoto H, Imai K, Perucho M. Gastrointestinal cancer of the microsatellite mutator phenotype pathway. J Gastroenterol 2002; 37: 153-63.
8. Catto JWF, Xinarianos G, Burton JL, et al. Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability. Int J Cancer 2003; 105: 484-90.
9. Vaish M, Mandhani A, Mittal RD, et al. Microsatellite instability as prognostic marker in bladder tumors: a clinical significance. BMC Urol 2005; 5: 2.
10. Christensen M, Jensen MA, Orntoft TF. Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer. Int J Cancer 1998; 79: 396-401.
11. Gonzalez-Zulueta M, Ruppert JM, Tokino K, et al. Microsatellite instability in bladder cancer. Cancer Res 1993; 53: 5620-23.
12. Li M, Zhang ZF, Reuter V, et al. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am J Pathol 1996; 149: 229-35.
13. Kawakami T, Shiina H, Igawa M, et al. Inactivation of the hMSH3 mismatch repair gene in bladder cancer. Biochem Biophys Res Commun 2004; 325: 934-42.
14. Furihata M, Shuin T, Takeuchi T, et al. Missense mutation of the hMSH6 and p53 gene in sporadic urothelial transitional cell carcinoma. Int J Oncol 2000; 16: 491-6.
15. Lawes DA, SenGupta S, Boulos PB. The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur J Surg Oncol 2003; 29: 201-12.
16. Gervaz P, Bucher P, Morel P. Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol 2004; 88: 261-6.
17. Saetta AA, Goudopoulou A, Korkolopoulou P, et al. Mononucleotide markers of microsatellite instability in carcinomas of the urinary bladder. Eur J Surg Oncol 2004; 30: 796-803.
18. Eble JN, Epstein JI, Seternhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics: Tumours of the Urinary System and Male Genital Tract. Lyon: IARC Press, 2004: 89-115.
19. th ed. New York: Wiley, 1997.
20. Mikulowski P, Hellsten S. T1G1 urinary bladder carcinoma: Fact or fiction? Scand J Urol Nephrol 2005; 39: 135-7.
21. Gotoh K, Yatabe Y, Sugiura T, et al. Frameshift mutations in TGFβRII, IGFIIR, BAX, hMSH3 and hMSH6 are absent in lung cancer. Carcinogenesis 1999; 20: 499-502.
22. Goudopoulou A, Saetta A, Korkolopoulou P, et al. p53 mutations detection in urinary bladder cancer in the Greek population: application of the NIRCA assay. J Exp Clin Cancer Res 2003; 22: 99-105.
23. Jin TX, Furihata M, Yamasaki I, et al. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder. Cancer 1999; 85: 478-84.
24. Hoang JM, Cottu PH, Thuille B, et al. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997; 57: 300-03.
25. Walsh AM, Bailly GG, Bell DG, et al. Microsatellite instability in multifocal urothelial carcinoma and effect on BAX and AXIN2. Can J Urol 2003; 10: 2000-6.
26. Amira N, Mourah S, Rozet F, et al. Non-invasive molecular detection of bladder cancer recurrence. Int J Cancer 2002; 101: 293-7.
27. Sardi I, Bartoletti R, Occhini I, et al. Microsatellite alterations in superficial and locally advanced transitional cell carcinoma of the bladder. Oncol Rep 1999; 6: 901-5.
28. Uchida T, Wang C, Wada C, et al. Microsatellite instability in transitional cell carcinoma of the urinary tract and its relationship to clinicopathological variables and smoking. Int J Cancer 1996; 69: 142-5.
29. Hosoya N, Hangaishi A, Ogawa S, et al. Frameshift mutations of the hMSH6 gene in human leukemia cell lines. Jpn J Cancer Res 1998; 89: 33-9.
30. Mishra SK, Mandhani A, Mittal RD, et al. Assessment of microsatellite instability in bladder and thyroid malignancies. Teratog Carcinog Mutagen 2003 (Suppl 1): 255-65.
31. Kim JH, Shariat SF, Kim IY, et al. Predictive value of expression of transforming growth factor-beta (1) and its receptors in transitional cell carcinoma of the urinary bladder. Cancer 2001; 92: 1475-83.
32. Chen J, Sadowski I. Identification of the mismatch repair genes PMS2 and MLH1 as p53 target genes by using serial analysis of binding elements. Proc Natl Acad Sci USA 2005; 102: 4813-8.
33. Oda S, Maehara Y, Ikeda Y, et al. Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability. Nucleic Acids Res 2005; 33: 1628-36.
34. Hussain SA, Ganesan R, Hiller L, et al. Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder. Br J Cancer 2003; 88: 586-92.
35. Korkolopoulou P, Christodoulou P, Lazaris A, et al. Prognostic implications of aberrations in p16/pRb pathway in urothelial bladder carcinomas: a multivariate analysis including p53 expression and proliferation markers. Eur Urol 2001; 39: 167-77.
36. Hartmann A, Zanardo L, Bocker-Edmonston T, et al. Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res 2002; 62: 6796-802.
37. Ericson KM, Isinger AP, Isfoss BL, et al. Low frequency of defective mismatch repair in a population-based series of upper urothelial carcinoma. BMC Cancer 2005; 1: 23.
38. Mongiat-Artus P, Miquel C, Van der Aa M, et al. Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract. Oncogene 2006; 25: 2113-8.
39. Hartmann A, Dietmaier W, Hofstadter F, et al. Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability. Hum Pathol 2003; 34: 222-7.